Marc Barthet

BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…

Severe gastroparesis (GP) is one of the major complications occurring in 15 to 40% of patients after esophagectomy with gastric pull-through despite recent progress in surgical techniques. GP significantly impacts the patients’ quality of life and nutritional status…